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Abstract
A family of homologous serine esterases designated granzyme A - H and the pore-forming
protein perforin are present in cytopiasmic granules of mature peripheral cytoiytic T lymphocytes
and natural killer cells. In vivo, the majority of cytotoxic T cells containing these granule-
associated proteins are of the CD4CD8+ phenotype. It is generally assumed that these cells are
derived from immature CD4-CD8- thymocytes. However, the precise intrathymic differentiation
steps leading to functionally mature cytotoxic T cells are unclear. Thus we decided to analyze
the expression of genes in the thymus which are preferentially expressed in mature cytotoxic
cells, i.e. granzyme A, granzyme B, and perforin. In situ hybridization on tissue sections revealed
the expression of genes coding for granzyme A and granzyme B in the thymus. No evidence was
found, however, for thymocytes expressing the perforin gene. Granzyme A and granzyme B
mRNA positive cells in the thymus are almost exclusively CD4CD8- thymocytes, particularly of
the CD3- IL2R- phenotype.
Introduction
Large cytopiasmic granules of cytotoxic T lymphocytes (CTL) and
natural killer (NK) cells contain among other molecules a family
of highly homologous serine proteases, designated granzyme
A - H (1) and the pore-forming protein perforin (2). Purified
perforin shows cytoiytic activity against red blood cells and certain
cell lines (3). The precise role of the serine proteases in cell-
mediated killing, however, is not known. Inhibition studies with
protease inhibitors including the synthetic inhibitor H-D-Pro-Phe-
Arg-chloromethyl-ketone, which selectively inhibits granzyme A,
indicated an important role for these proteases in cell-mediated
cytolysis (4,5). However, no direct cytotoxic effects of purified
granzyme A against various normal and tumor target cells were
found (6), implying a more indirect role for this protease in cell-
mediated cytolysis. Other functions, not directly related to cell-
mediated cytotoxicity, such as an involvement in B cell activation
or degradation of extracellular matrix (7), were also proposed
for serine proteases in T lymphocytes. In vivo, the majority of
the perforin- and granzyme-containing CTL seem to be of
the CD4-CD8+ phenotype (8-11), although a minor fraction
of Thy-1 + CD4 + CD8- peripheral T cells also express the
granzyme A gene in vivo (8).
It is generally assumed that peripheral CD4+CD8- and
CD4-CD8+ T cells differentiate from immature CD4-CD8-
thymocytes, the so-called double negative thymocytes (DN), via
a CD4+CD8+ intermediate. The intrathymic differentiation
step(s) leading to functionally mature cytotoxic T cells are unclear
(for review see ref. 12). We decided to address this question by
analyzing the expression of genes in the thymus that are
preferentially associated with mature cytotoxic cells, i.e. granzyme
A (1), granzyme B (1), and perforin (13).
Methods
Preparation of labeled RNA probes
A 775 bp cDNA fragment of the granzyme A gene [also
designated HF and kindly provided by I. L. Weissman (14); this
gene has also been named CTLA-3 (15), TSP-1 (6), BLT esterase
(16), or serine esterase 1 (17)], a 1.1 kb fragment of the granzyme
B gene [also designated CCP-1/C11 and kindly provided by
R. C. Bleackley (18); this gene has also been named CTLA-1 (15)
or serine esterase 2 (17)], a 521 bp cDNA fragment of the
perforin gene (kindly provided by H. Hengartner, 13) and a 1.1 kb
fragment of the IL2R p55 chain gene (19, kindly provided by
D. Pardoll, Bethesda) were subcloned into the transcription vector
pGEM 1 using standard techniques. After linearization of the
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plasmids with the appropriate restriction endonucleases, 35S-
labeled antisense and sense RNA probes were prepared using
T7 and SP6 RNA polymerases, respectively, as previously
described in detail (8).
In situ hybridization
In situ hybridization was performed on 5 ^ m thick frozen sections
of the thymus from 6- to 8-week-old C57BL/Ka or BALB/c mice
as previously described in detail (8). In brief, tissue sections were
fixed in 4% PBS-buffered paraformaldehyde for 20 min before
proteinase K treatment. After post-fixation in paraformaldehyde
and acetylation the hybridization was performed with 2 x 105
cpm 35S-labeled RNA probe//*! of hybridization solution for 18 h
at 48°C. After digestion of single-stranded, non-hybridized RNA
with RNase A and T1 and extensive washing, slides were dipped
into NTB 2 nuclear track emulsion (Eastman Kodak). Hybridized
slides were exposed for 10-20 days in a light-tight box at
-70°C, developed and subsequently counterstained with
nuclear fast red (0.05% in 5% aluminium sulfate).
Flow microfluorometry and cell sorting
Total C57BL/6 thymocytes were stained with a mixture of FITC-
coupled anti-CD8 mAb H35-17.2 (20) and phycoerythrin (PE)-
coupled anti-CD4 mAb GK-1.5 (21) and fixed immediately with
3% paraformaldehyde. The four major thymocyte subsets
(CD4-CD8-, CD4+CD8 + , CD4+CD8-, and CD4-CD8+) were
sorted according to the two-color fluorescence distribution.
For analysis of immature thymocyte subsets, CD4-CD8-
cells were first purified by treatment with a mixture of rat IgM
mAbs RL172.4 (anti-CD4) and 3.168.1 (anti-CD8) in the presence
of rabbit complement as described in detail elsewhere (22).
CD4-CD8- thymocytes were further stained, fixed, and sorted
according to their expression of IL-2 receptor (p55 chain) or CD3
using rat mAbs PC61.5 (23) and 17A2 (G. Miescher and
H. R. MacDonald, unpublished data), respectively. In most
experiments, — 104 sorted cells were deflected directly onto
pre-cleaned and poly-L-lysine-coated microscopic slides. In situ
hybridization on sorted thymocytes was performed as described
above for tissue sections.
Evaluation of in situ hybridizations
Tissue sections and cell preparations were hybridized with ^S-
labeled antisense RNA probes and, as a negative control, also
with the respective sense probe which is identical to the cellular
target mRNA. After hybridization with an antisense probe, cells
were considered positive for gene expression when they had at
least three times as many silver grains as cells hybridized with
the corresponding sense RNA probe. For the assessment of the
frequency of mRNA-positive cells, usually 2000-3000 isolated
thymocytes were considered for evaluation.
Results
Localization of gene expression in the adult thymus
Frozen sections of the thymus from 6- to 8-week-old C57BL/Ka
mice were hybridized in situ with 35S-labeled antisense RNA
probes for the genes coding granzyme A, granzyme B, and
perforin. Cells expressing granzymes A and B were regularly
observed on thymus sections, whereas no evidence for
Fig. 1. Expression of the granzyme A, granzyme B, and IL2R genes
in the thymus of a 6-week-old C57BL/Ka mouse. Dark-field
photomicrographs show frozen sections of the thymus hybridized in situ
with radiolabeled antisense RNA probes. Granzyme A gene expression
is mainly observed scattered throughout the thymic cortex (ct) (A).
Granzyme B-positive cells are predominantly found in the medullary area
(md) of the thymus whereas cells containing IL2R mRNA are found in
both the thymic cortex and the medullar (C). Scale bars represent
50 ^m and the dashed line indicates the cortico-medullary junction.
transcription of the perforin gene was found. Cells expressing
granzyme A are almost exclusively located scattered throughout
the thymic cortex, at slightly increased numbers in the
subcapsular zone (Fig. 1 A). They are much more frequent than
granzyme B-positive cells which are predominantly found at a
low frequency in the medullary area of the thymus (Fig. 1B).
The IL2R p55 chain is expressed on the cell surface of a distinct
subset of early DN (23). Its expression in the thymus was
previously characterized with the monoclonal anti-IL2R antibody
PC61.5. Immunostainings with PC61.5 revealed the presence
of positive cells scattered throughout the thymic cortex and
medulla (23). We analyzed the expression of the IL2R gene in
comparison to the IL2R surface expression to determine their
correlation and as an internal control for the staining and sorting
procedure. Cells containing IL2R mRNA were found in both the
thymic cortex and the medulla (Fig. 1C). Generally, positive cells
in the cortex showed a higher number of IL2R transcripts than
positive cells in the medulla as was assessed by the number of
silver grains over positive cells on tissue sections.
In order to determine whether the observed expression of
granzyme A, granzyme B, perforin, and IL2R is unique to the
C57BL/Ka mouse strain we also hybridized thymus sections of
BALB/c mice with the respective RNA probes. Granzyme A and
IL2R gene expression was slightly more prominent in the
subcapsular region of the thymus from BALB/c mice. However,
the frequency and localization of mRNA-positive thymocytes did
not differ significantly between BALB/c and C57BL/Ka mice (not
shown).
Phenotype of thymocytes expressing the genes for granzyme
A and granzyme B
The frequency of thymocytes which are positive for the expression
of a particular gene was determined by in situ hybridization on
cytospins of thymocyte suspensions. About 1.3% of total
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Table 1 . Phenotype of thymocytes expressing the genes for granzyme A and granzyme B
Thymic subset
Total thymocytes
CD4+CD8"
CD4-CD8+
CD4+CD8+
CD4-CD8-
% of total
thymocytes
100
10
4
83
3
Gene probe
Granzyme Aa
1.3 ± 0.4
0
1.5 ± 0.6
0
23.1 ± 3.7
Granzyme Ba
+ b
0
0
0
2.2 ± 0.6
IL2Ra
1.5 ± 0.4
0.5 ± 0.2
0
0
26.2 ± 4.6
aPercentage of mRNA-positive cells in the respective thymocyte subsets. Data represent means ± SD of three different experiments.
bPositive cells are occasionally observed.
, . *
/ *
Fig. 2. Granzyme A gene expression in CD4~ CD8~ CD3~ IL2R- and CD4- CD8- CD3~ IL2R+ thymocytes. Thymocyte subpopulations were isolated
and subsequently hybridized in situ at the single-cell level with the 3t)S-labeled antisense RNA probe of the granzyme A gene. The bright-field
photomicrograph shows CD4-CD8- CD3~ IL2R- thymocytes (A) with a high percentage of granzyme A gene-expressing cells which are easily
seen in the dark-field (B). Selected positive cells are arrowed. Only a few granzyme A mRNA-positive cells (arrowed) are found among CD4~CD8-
IL2R+ thymocytes (C,D). Scale bars represent 50 ^m.
thymocytes are positive for granzyme A mRNA, whereas
granzyme B positive cells are at least 5 -10 times less frequent.
IL2R mRNA-positive cells represent — 1.5% of total thymocytes
(Table 1). A slightly higher portion of thymocytes express IL2R
protein on their surface (23).
For the phenotypic characterization of thymocytes expressing
the granzyme A or granzyme B gene, thymocytes were first
separated into the four major subsets, i.e. CD4+CD8- (10% of
total thymocytes), CD4-CD8+ (4%), CD4+CD8+ (83%), and
CD4-CD8- (3%), the so-called double negative thymocytes
(DN), using a fluorescence-activated cell sorter (FACS). Separated
thymocytes were subsequently hybridized at the single cell level
with radiolabeled antisense RNA probes. Granzyme A, granzyme
B, and IL2R mRNA-positive cells are almost exclusively found
in the most immature of the four major thymic subsets, i.e. in DN.
Very few CD4-CD8+ thymocytes (1.5%) were also found to
express the granzyme A gene (Table 1).
Recently an immature subpopulation of CD4-CD8+
thymocytes was identified which does not express the T cell
receptor (TCR)-associated CD3 complex (24). Therefore
CD4-CD8+ thymocytes which contain - 1 .5% granzyme A
mRNA-positive cells were further separated into a CD3+ (70%
of CD4-CD8+) and a CD3- (30%) subset and subsequently
Table 2. Phenotype
gene for granzyme
CD4-CD8+ CD3 +
CD4-CD8+ CD3-
Ot
A
CD4-CD8+ thymocytes
% of total
thymocytes
3
1
expressing the
Granzyme Aa
1.5
19.2
Percentage of mRNA-positive cells in the respective thymocyte
subset. Data represent means of two different experiments.
hybridized with an antisense RNA probe of the granzyme A gene:
mature thymocytes of the CD3+ CD4-CD8+ phenotype contain
a very small fraction of granzyme A mRNA-positive cells (1.5%),
whereas - 2 0 % positive cells are found in the corresponding
immature CD3- CD4-CD8+ subpopulation (Table 2).
Cells expressing genes for granzymes A and B in subsets of
CD4 - CD8 - thymocytes
DN, which contain the precursors of all other major thymic
subsets (25), are functionally and phenotypically very hetero-
geneous and account for only 2 - 4% of total cells in the thymus
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Table 3. Cells expressing genes for granzymes A and B in subsets of CD4-CD8- thymocytes
Population8
A
B
C/D
CD4-CD8- subset
total CD4-CD8-
IL2R- CD3-
IL2R+ CD3-
IL2R- CD3 +
% of
CD4-CD8-
100
30
45
25
Gene probeb
Granzyme A
25.0
48.1
7.8
29.6
Granzyme B
2.1
2.8
1.0
2.6
IL2R
28.7
5.5
68.4
1.0
aNomenclature according to ref. 12.
bPercentage of mRNA-positive cells in the respective thymocyte subset. Data represent means of two different experiments.
(22). They can be divided into subpopulations according to the
surface expression of the IL2R and the CD3 antigen: population
A consists of DN IL2R- CD3- thymocytes (30% of DN), which
are enriched for rapidly cycling thymocytes. Population B
includes DN IL2R + CD3- thymocytes (45% of DN). Populations
C/D are DN IL2R- CD3+ thymocytes (25% of DN); the CD3
antigen is associated with a functional TCR of either the y/8
(population C) or a//3 type [population D; for review see
MacDonald et al. (12)].
The distribution of cells expressing genes for granzymes A and
B among DN thymocytes was determined by separating the DN
subsets by FACS and subsequent in situ hybridization with RNA
probes. About 8% of IL2R-positive cells (population B) were found
positive for granzyme A gene expression. This frequency is ~6
times higher in the IL2R-negative population A. About 30%
granzyme A mRNA-positive cells are associated with the CD3 +
phenotype (populations C/D). The distribution of cells transcribing
the granzyme B gene is similar, as the lowest frequency of positive
cells was found in population B. About 2.5% granzyme
B-expressing cells are found in each of the two remaining DN
subsets (Table 3). Cells transcribing the IL2R gene are mainly
observed in population B, where IL2R is expressed on the
surface. However, few cells containing IL2R mRNA are also found
in population A and in the CD3+ DN subset (C/D), both of which
do not express IL2R protein on their surface (Table 3).
Discussion
In situ hybridizations with radiolabeled RNA probes revealed the
expression of genes in the thymus which are preferentially
induced in mature cytotoxic cells, i.e. ganzyme A and granzyme
B. However, considerable differences of gene expression in the
thymus and in cell-mediated cytotoxic reactions in the periphery
were observed: in particular, granzyme B-expressing thymocytes
are —10 times less frequent than granzyme A mRNA-containing
cells. This is in marked contrast to the situation observed in
peripheral cytotoxic cells involved in the rejection of a MHC
mismatched graft or in the clearance of liver cells infected with
lymphotropic choriomeningitis virus (8,9). During these reactions,
granzyme B-expressing cells are present in equal or even higher
numbers than granzyme A-positive cells. Expression of the
granzyme A and granzyme B genes in the thymus was almost
exclusively observed in DN, i.e. in cells which are not cytolytic
unless being activated. These observations imply that the
expression of the two genes in the thymus is differentially
regulated and that the two serine esterases are not strictly
associated with cytotoxicity. Furthermore, the absence of
detectable perforin mRNA in thymocytes may imply that the
function of granzymes is largely if not completely independent
of perforin.
About 1.5% of granzyme A mRNA-positive cells are observed
among mature, CD3-expressing CD4-CD8+ thymocytes. This
corresponds with the reported frequency of granzyme A-
expressing CD8+ T cells in the spleen (8). The CD3-
CD4-CD8+ population, which may represent a transient stage
between DN and CD4+CD8+ thymocytes (24), contains - 2 0 %
granzyme A-expressing cells. Most likely these thymocytes were
excluded from the CD4-CD8+ thymocyte preparation when
sorting total thymocytes since they are CD8du". This would
explain the discrepancy in the percentages of granzyme A-
expressing cells when looking at total CD4-CD8+ thymocytes
in Table 1 compared to the total of the two CD4-CD8+ subsets.
Generally, a slight discrepancy was found between the percen-
tage of specific mRNA-positive cells in unfractionated thymocytes
and in the total of all sorted thymocyte subpopulations. Most likely,
the mRNA is slowly degraded during the prolonged staining and
isolation procedure and is finally undetectable by in situ
hybridization in thymocytes with a low expression level of a
particular gene.
Therefore we analyzed the expression of the IL2R, which is
expressed at the protein level on an early DN subset (population
B) (23). Immunostaining and in situ hybridization on thymus
sections revealed a similar pattern of positive cells for IL2R mRNA
and surface protein, respectively. IL2R mRNA-positive cells are
predominantly IL2R surface protein positive. Differences between
IL2R gene and protein expression are likely to reflect the in vivo
situation of transient gene activation and surface expression. It
may also be due in part to differences in the half-life of protein
and transcript which becomes increasingly apparent with
prolonged isolation procedures.
Granzyme A expression in mature cytotoxic cells can be
induced by antigen in combination with lymphokines (26,27) or
by culturing in the presence of IL2 (28). Both activation
mechanisms are unlikely to be operative in immature DN IL2R-
CD3- thymocytes since these cells do not express TCR and
activation of the granzyme A (and B) gene does not correlate
with expression of the IL2R on both mRNA and protein level.
Furthermore, we did not find evidence for IL2 gene transcrip-
tion with in situ hybridization on thymus sections (W.Held and
C.Mueller, unpublished data).
Based on the observed high percentage of granzyme A-
expressing cells in population A and their predominant blast-like
morphology, we suggest that granzyme A expression
corresponds to cells in cycle rather than to a particular phenotype.
This is true for population A, where 50% of the cells are in S +
G2 + M phase of the cell cycle (22,29) and 48% of the cells
express the gene for granzyme A. In the IL2R-expressing DN
subset (population B) both the number of cycling and granzyme
A-expressing cells are similarly reduced compared to population
A. The CD3- CD4-CD8+ subpopulation represents another
rapidly cycling thymocyte population which again contains a large
portion of granzyme A-positive cells. The current view of
intrathymic differentiation suggests a lineage from population B
to population A to CD3- CD4-CD8+ cycling cells to double
positive, i.e. CD4 + CD8 + , thymocytes (24,29). Thus, the
granzyme A gene is induced during the early differentiation steps
of thymocytes and the number of cells expressing this gene
parallels the portion of cells in cycle. However, at present we do
not have further evidence to confirm the relation between cell
cycle status and granzyme A expression at the single cell level.
The precise function of the serine protease granzyme A in the
thymus as well as in CTL in the periphery is not clear. The function
for granzyme A in the thymus is most likely different from an
involvement in cytotoxic reactions since DN thymocytes are not
cytolytic per se. One could think of an involvement of granzymes
in the degradation of extracellular matrix proteins (7), thus
facilitating intrathymic migration of thymocytes during their
differentiation. Detection of granzyme proteins, their intracellular
localization, and substrate specificity in the thymus should provide
further information about the precise role of granzymes in both
thymocytes and CTL.
It is tempting to speculate that expression of granzymes in the
thymus represents an early, perhaps transient event in T cell
differentiation, eventually leading to functional T cells with
inducible cytotoxic activity. At present, it is not clear whether all
DN thymocytes express granzyme A at some point during their
maturation or whether cells expressing granzymes represent
distinct thymic subsets, characterizing distinct differentiation
lineages. In vitro differentiation and in vivo reconstitution assays
with granzyme-positive and -negative thymocyte subsets may
become useful to determine the functional properties and in vivo
differentiation potential of thymocytes expressing granzymes.
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